Improving Global Healthcare Through Clinical Lab 2.0

6th ANNUAL

CLINICAL LAB 2.0 WORKSHOP

March 6-7, 2023 • Pendry Chicago

Convergence of Diagnostics and Population Health:
a Project Santa Fe Foundation Publication

Join the global movement from test volume to lab value.

The world of healthcare is changing – the clinical laboratory is changing with it. While the traditional, transactional lab model continues to serve as a foundation, the emerging Clinical Lab 2.0 business model leverages longitudinal laboratory data to produce actionable, clinical insight, driving better outcomes for patients, providers, and financial stakeholders alike.

Clinical Lab 2.0 re-engineers the role of lab in the care continuum, aligning with the future of value-based healthcare.

We are fortunate to have these Industry Partners supporting the

Clinical Lab 2.0 movement, true partners in developing the solutions.

Clinical Lab 2.0 is widely featured

Improving Global Healthcare Through Clinical Lab 2.0

Clinical Lab 2.0 Partner Insight

SPOTLIGHT

Elevating the CBC: From the Lab to the Cloud

Learn More and View the Presentation

Meet the Leadership

View the Board of Directors

Khosrow R. Shotorbani, MBA, MT(ASCP)

Michael J. Crossey, MD, PhD

James M. Crawford, MD, PhD

Myra L. Wilkerson, MD

Richard J. Zarbo, MD, DMD

Mark K. Fung, MD, PhD

Curtis A. Hanson, MD

Karen L. Kaul, MD, PhD

Sterling T. Bennett, MD, MS

Thomas S. Lorey, MD

Heard in the industry

“Laboratory medicine, while continuing to support a transactional business model, should expand efforts to include translational data analytics, proving its clinical and economic valuation”

Journal of Applied Laboratory Medicine

“An intriguing and stimulating chance to meet with thought leaders and interact with other executives facing the need to reorient their labs to a value-based perspective”